414 related articles for article (PubMed ID: 34183987)
1. Molecular mechanisms in Alzheimer's disease and the impact of physical exercise with advancements in therapeutic approaches.
Siddappaji KK; Gopal S
AIMS Neurosci; 2021; 8(3):357-389. PubMed ID: 34183987
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs.
Thakral S; Yadav A; Singh V; Kumar M; Kumar P; Narang R; Sudhakar K; Verma A; Khalilullah H; Jaremko M; Emwas AH
Ageing Res Rev; 2023 Jul; 88():101960. PubMed ID: 37224884
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach.
Morató X; Pytel V; Jofresa S; Ruiz A; Boada M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012569
[TBL] [Abstract][Full Text] [Related]
5. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
6. Current druggable targets for therapeutic control of Alzheimer's disease.
Gupta GL; Samant NP
Contemp Clin Trials; 2021 Oct; 109():106549. PubMed ID: 34464763
[TBL] [Abstract][Full Text] [Related]
7. Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology.
Hassan NA; Alshamari AK; Hassan AA; Elharrif MG; Alhajri AM; Sattam M; Khattab RR
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956796
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Approach to Alzheimer's Disease: Current Treatments and New Perspectives.
Pardo-Moreno T; González-Acedo A; Rivas-Domínguez A; García-Morales V; García-Cozar FJ; Ramos-Rodríguez JJ; Melguizo-Rodríguez L
Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745693
[TBL] [Abstract][Full Text] [Related]
10. Current Strategies and Novel Drug Approaches for Alzheimer Disease.
Ghai R; Nagarajan K; Arora M; Grover P; Ali N; Kapoor G
CNS Neurol Disord Drug Targets; 2020; 19(9):676-690. PubMed ID: 32679025
[TBL] [Abstract][Full Text] [Related]
11. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
Bowirrat A
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
[TBL] [Abstract][Full Text] [Related]
12. Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective.
Rajah Kumaran K; Yunusa S; Perimal E; Wahab H; Müller CP; Hassan Z
J Alzheimers Dis; 2023; 91(2):507-530. PubMed ID: 36502321
[TBL] [Abstract][Full Text] [Related]
13. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
14. Beyond the classical amyloid hypothesis in Alzheimer's disease: Molecular insights into current concepts of pathogenesis, therapeutic targets, and study models.
Theerasri A; Janpaijit S; Tencomnao T; Prasansuklab A
WIREs Mech Dis; 2023 Mar; 15(2):e1591. PubMed ID: 36494193
[TBL] [Abstract][Full Text] [Related]
15. Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments.
Seyedaghamiri F; Rajabi M; Mohaddes G
Neurochem Res; 2023 Jan; 48(1):26-38. PubMed ID: 36048350
[TBL] [Abstract][Full Text] [Related]
16. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
17. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
Sahoo AK; Dandapat J; Dash UC; Kanhar S
J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
[TBL] [Abstract][Full Text] [Related]
18. A review on Alzheimer's disease pathophysiology and its management: an update.
Kumar A; Singh A; Ekavali
Pharmacol Rep; 2015 Apr; 67(2):195-203. PubMed ID: 25712639
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer's disease.
Das BC; Dasgupta S; Ray SK
Neural Regen Res; 2019 Nov; 14(11):1880-1892. PubMed ID: 31290437
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
